Evofem Biosciences, Inc. Stock price
Is Evofem Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Evofem Biosciences, Inc. Stock Analysis
Analyst Opinions
6 Analysts have issued a Evofem Biosciences, Inc. forecast:
Analyst Opinions
6 Analysts have issued a Evofem Biosciences, Inc. forecast:
Don't miss a Thing! We will send you all news about Evofem Biosciences, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Evofem Biosciences, Inc. Stock News
Company Profile
Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.
| Head office | United States |
| CEO | Ms. Pelletier |
| Employees | 32 |
| Founded | 2007 |
| Website | www.evofem.com |


